Keywords: bi, avonex, shows, little, benefit, higher, doses

BI's Avonex shows little benefit at higher doses

Article | 04 July 2005

Print This

US biotechnology firm Biogen Idec says that new data from a retrospective analysis of its drug Avonex (interferon beta-1a) ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in